why choose us

Clinical Trials Search

Showing 1,220 of 132,085 result(s)
Second-generation Radiofrequency Application and Therapeutic Exercise for Stress Urinary Incontinence

Status: COMPLETED

Condition: Stress Urinary Incontinence

Interventions: This is a self-administered questionnaire with four questions and a total score ranging from 0 [best] to 21 [worst] that identifies people with urinar

Date: 2025-07-24

Helping Stroke Patients With Movement Using Photos, Videos, and Pictograms

Status: COMPLETED

Condition: Stroke

Interventions: Participants will be presented with three types of visual instructional aids: photographs, videos, and pictograms, via a laptop or tablet.
Each p

Date: 2025-07-24

Safety, Reactogenicity, and Immunogenicity Trial of STX-S SARS-CoV-2 Vaccine in Adults

Status: COMPLETED

Condition: COVID-19

Interventions: BIOLOGICAL: STX-S - A proprietary vaccine developed internally by Capricor utilizing exosomes that were engineered to express spike proteins on the su

Date: 2025-07-24

Effectiveness of Laparoscopic Lateral Suspension With or Without Hysterectomy in Pelvic Organ Prolapse

Status: COMPLETED

Condition: Pelvic Organ Prolapse (POP)

Interventions:

Date: 2025-07-23

Textural Analysis and Effect of ROI Size on Infrared Thermography in Athletes With Patellar Tendinopathy

Status: COMPLETED

Condition: Patellar Tendinopathy

Interventions: The IT images were recorded with an OPTRIS PI 450 IRT camera coupled to Optris PI Connect Software (Germany).
The IRT camera has a Noise Equivale

Date: 2025-07-23

Evaluating the Impact of Fat and Sugar Replacer Blends on Gastrointestinal Tolerance in Biscuits

Status: COMPLETED

Condition: Gastrointestinal Tolerance

Interventions: Acute intake

Date: 2025-07-23

A Study in Healthy Men to Test How Bosentan Influences the Amount of Nerandomilast in the Blood

Status: COMPLETED

Condition: Healthy

Interventions: Nerandomilast

Date: 2025-07-22

Real-world Outcomes Among Patients With Melanoma Treated With Neoadjuvant Nivolumab+Relatlimab or Nivolumab+Ipilimumab

Status: COMPLETED

Condition: Melanoma

Interventions: As prescribed by the treating clinician

Date: 2025-07-22

A Study Evaluating the Effect of Daily Oral RO7795081 in Participants With Obesity or Overweight With at Least One Weight-Related Comorbidity

Status: COMPLETED

Condition: Obesity or Overweight

Interventions: DRUG: RO7795081 - RO7795081 will be administered orally once daily, according to the randomized dosing regimen, during the 38-week treatment period.

Date: 2025-07-22

Improvement and Safety of Nutrilite Protein MetX Pro on Weight Management in Overweight Individuals With Dyslipidemia

Status: COMPLETED

Condition: Dyslipidemia

Interventions: A total of 4 cans (460 g;can) of study products (Nutrilite Protein MetX Pro) are distributed to each participant.
Participants need to take

Date: 2025-07-22